4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.
Use this FDMT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the FDMT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the FDMT SEC filings page. Lician reads the product cache first so this HTML stays unique to 4D Molecular Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full FDMT income, balance, and cash tables.